Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
44.07
-2.79 (-5.95%)
At close: Jan 30, 2026, 4:00 PM EST
43.82
-0.25 (-0.57%)
After-hours: Jan 30, 2026, 7:59 PM EST
Moderna Market Cap
Moderna has a market cap or net worth of $17.22 billion as of January 30, 2026. Its market cap has increased by 28.70% in one year.
Market Cap
17.22B
Enterprise Value
11.31B
1-Year Change
28.70%
Ranking
Category
Stock Price
$44.07
Market Cap Chart
Since December 7, 2018, Moderna's market cap has increased from $6.12B to $17.22B, an increase of 181.44%. That is a compound annual growth rate of 15.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 17.22B | 49.44% |
| Dec 31, 2025 | 11.52B | -27.99% |
| Dec 31, 2024 | 16.00B | -57.80% |
| Dec 29, 2023 | 37.92B | -45.05% |
| Dec 30, 2022 | 69.01B | -32.99% |
| Dec 31, 2021 | 102.98B | 149.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Royalty Pharma | 24.06B |
| Genmab | 19.81B |
| Incyte | 19.65B |
| Revolution Medicines | 18.74B |
| Roivant Sciences | 15.04B |
| BridgeBio Pharma | 14.89B |
| Ascendis Pharma | 13.88B |
| Ionis Pharmaceuticals | 13.39B |